Opinion
Civil Action 2:22-CV-00334-JLR
12-22-2023
HDT BIO CORP., Plaintiff, v. EMCURE PHARMACEUTICALS LTD., Defendant.
STOKES LAWRENCE, P.S. By: Mathew L. Harrington, WSBA#33276 Justo Gonzalez, WSBA#39127 Peter K. Stris Dana Berkowitz Kenneth J. Halpern John Stokes Stris & Maher, LLP Attorneys for Plaintiff HDT Bio Corp. PERKINS COIE LLP By: James Sanders, WSBA No. 24565 Amanda J. Beane, WSBA No. 33070 Eric B. Wolff, WSBA No. 43047 Steven W. Fogg Todd Williams Corr Cronin, LLP Attorneys for Defendant Emcure Pharmaceuticals LTD.
STOKES LAWRENCE, P.S. By: Mathew L. Harrington, WSBA#33276 Justo Gonzalez, WSBA#39127 Peter K. Stris Dana Berkowitz Kenneth J. Halpern John Stokes Stris & Maher, LLP Attorneys for Plaintiff HDT Bio Corp.
PERKINS COIE LLP By: James Sanders, WSBA No. 24565 Amanda J. Beane, WSBA No. 33070 Eric B. Wolff, WSBA No. 43047 Steven W. Fogg Todd Williams Corr Cronin, LLP Attorneys for Defendant Emcure Pharmaceuticals LTD.
ORDER GRANTING THE PARTIES' STIPULATED MOTION TO EXTEND BRIEFING SCHEDULE ON EMCURE'S MOTION FOR ATTORNEY FEES
Honorable James L. Robart United States District Judge
THIS MATTER comes before the Court on Plaintiff HDT Bio Corp, and Defendant Emcure Pharmaceutical Ltd.'s Stipulated Motion to Extend Briefing Schedule on Emcure's Motion for Attorney Fees (the “Stipulated Motion”). The Court, having reviewed the Stipulated Motion, orders as follows:
IT IS HEREBY ORDERED that the Stipulated Motion is GRANTED; and
IT IS FURTHER ORDERED that the deadline for HDT to file its opposition to Emcure's motion for attorney fees is January 22,2024. Emcure may file its reply on or before February 5,2024.